Thomas Kirchner

Active 1985–2024

196
Papers
29,257
Citations
94
h-index
182
i10-index

Citations

Citations per year for Thomas Kirchner1928: 1 citations1972: 1 citations1980: 1 citations1986: 1 citations1987: 1 citations1988: 3 citations1989: 2 citations1990: 2 citations1991: 2 citations1992: 1 citations1993: 9 citations1994: 11 citations1995: 11 citations1996: 13 citations1997: 19 citations1998: 15 citations1999: 23 citations2000: 42 citations2001: 79 citations2002: 103 citations2003: 120 citations2004: 107 citations2005: 142 citations2006: 156 citations2007: 161 citations2008: 198 citations2009: 218 citations2010: 225 citations2011: 263 citations2012: 308 citations2013: 372 citations2014: 363 citations2015: 386 citations2016: 342 citations2017: 386 citations2018: 364 citations2019: 1,072 citations2020: 1,112 citations2021: 1,091 citations2022: 810 citations2023: 541 citations2024: 785 citations2025: 381 citations2026: 14 citations1929–1971: no citations, so these years are not shown1973–1979: no citations, so these years are not shown1981–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,369 citing papers, 23.3% of this breakdownChina: 1,611 citing papers, 11.1% of this breakdownGermany: 1,318 citing papers, 9.1% of this breakdownUnited Kingdom: 833 citing papers, 5.8% of this breakdownItaly: 734 citing papers, 5.1% of this breakdownFrance: 530 citing papers, 3.7% of this breakdownJapan: 519 citing papers, 3.6% of this breakdownNetherlands: 471 citing papers, 3.2% of this breakdownSpain: 422 citing papers, 2.9% of this breakdownCanada: 393 citing papers, 2.7% of this breakdownAustralia: 378 citing papers, 2.6% of this breakdownSwitzerland: 345 citing papers, 2.4% of this breakdown
0%23.3%Other 24.5%

Fields

  • Medicine55.4%
  • Biochemistry, Genetics and Molecular Biology31.1%
  • Immunology and Microbiology4.5%
  • Engineering1.9%
  • Neuroscience1.2%
  • Psychology1.2%
  • Other4.7%

Topics

  • Cancer Cells and Metastasis5.1%
  • Colorectal Cancer Treatments and Studies3.2%
  • Cancer Genomics and Diagnostics2.6%
  • Cancer Immunotherapy and Biomarkers2.4%
  • Wnt/β-catenin signaling in development and cancer2.1%
  • Genetic factors in colorectal cancer2%
  • Other82.6%

Coauthors

All papers

Open in search
  1. Sarcoma classification by DNA methylation profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schick, Melanie Bewerunge‐Hudler, Till Milde, Olaf Witt, Andreas E. Kulozik, Marcel Kool, Laura Romero‐Pérez, Thomas G. P. Grünewald, Thomas Kirchner, Wolfgang Wick, Michael Platten, Andreas Unterberg, Matthias Uhl, Amir Abdollahi, Jürgen Debus, Burkhard Lehner, Christian Thomas, Martin Hasselblatt, Werner Paulus, Christian Hartmann, Ori Staszewski, Marco Prinz, Jürgen Hench, Stephan Frank, Yvonne M.H. Versleijen‐Jonkers, Marije E. Weidema, Thomas Mentzel, Klaus Griewank, Enrique de Álava, Juan Díaz‐Martín, Miguel Á. Idoate, Kenneth Tou En Chang, Sharon Y. Y. Low, Adrián Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek, Stefan Rutkowski, Ulrich Schüller, Viktor Mautner, Jens Schittenhelm, Jonathan Serrano, Matija Snuderl, Reinhard Büttner, Thomas Klingebiel, Rolf Buslei, Manfred Gessler, Pieter Wesseling, Winand N.M. Dinjens, Sebastian Brandner, Zane Jaunmuktane, Iben Lyskjær, Peter Schirmacher, Albrecht Stenzinger, Benedikt Brors, Hanno Glimm, Christoph Heining, Òscar M. Tirado, Miguel Sáinz‐Jaspeado, Jaume Mora, Javier Alonso, Xavier García del Muro, Sebastián Morán, Manel Esteller, Jamal Benhamida, Marc Ladanyi, Eva Wardelmann, Cristina R. Antonescu, Adrienne M. Flanagan, Uta Dirksen, Peter Hohenberger and 11 more - Nature Communications 2021 cited by 547

  2. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 1,741

  3. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2012 cited by 1,077

  4. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

    Authors: , , , , , , , , , , , , , , , , - Annals of Oncology 2016 cited by 344

  5. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 453

  6. gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2009 cited by 939

  7. FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

    Authors: , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2020 cited by 188

  8. Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 158

  9. Frequency and Type of KRAS Mutations in Routine Diagnostic Analysis of Metastatic Colorectal Cancer

    Authors: , , , - Pathology - Research and Practice 2009 cited by 358

  10. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 418

  11. Loss of p53 in Enterocytes Generates an Inflammatory Microenvironment Enabling Invasion and Lymph Node Metastasis of Carcinogen-Induced Colorectal Tumors

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2012 cited by 302

  12. Migrating cancer stem cells — an integrated concept of malignant tumour progression

    Authors: , , , , - Nature reviews. Cancer 2005 cited by 1,346

  13. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis

    Authors: , , , , , , , , - Gastroenterology 1992 cited by 752

  14. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer

    Authors: , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2020 cited by 108

  15. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 1,032

  16. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Düring, Jens Ebentheuer, Christopher Fricke, Alexander L. Gerbes, Stefan Jun Groiss, Doreen Gruber, Christian J. Hartmann, Thomas Kirchner, Daniel Kroneberg, Martin Kunz, Stefan Lorenzl, Alexia Moldovan, Anna H. Noda, Heidi Pape, Gesine Respondek, Eva Schäffer, Martina Schneider, Alfons Schnitzler, Walter Schulz‐Schaeffer, Johannes Schwarz, Cornelia Skowronek, Alexander Storch, Vera Tadić, Dávid Vadász, Benno F. Zimmermann - The Lancet Neurology 2019 cited by 126

  17. Pig-to-non-human primate heart transplantation: The final step toward clinical xenotransplantation?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Walz, Thomas Kirchner, David Ayares, Karen Lampe, Uwe Schönmann, Christian Hagl, Eckhard Wolf, Nikolai Klymiuk, Jan‐Michael Abicht, Paolo Brenner - The Journal of Heart and Lung Transplantation 2020 cited by 88

  18. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 cited by 81

  19. The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 63

  20. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Françoise Smets, Susana Corujeira, Myriam Van Winckel, Stephan Buderus, Sonny K. F. Chong, Steffen Husby, Sibylle Koletzko, Piotr Socha, Božena Cukrowská, Hania Szajewska, J Wyhowski, Nailah Brown, Gauri Batra, Zrinjka Mišak, Sven Seiwerth, Yulia Dmitrieva, Д. С. Абрамов, Yvan Vandenplas, Annieta Goossens, Maaike W. Schaart, Vincent T.H.B.M. Smit, Nicolas Kalach, Philippe Gosset, Judit B. Kovács, Anikó Nagy, Ilona Lellei, Rita Kőbányai, Katayoun Khatami, Maryam Monajemzadeh, Konstantina Dimakou, Amalia Patereli, Tine Plato Hansen, Rajko Kavalar, Miguel Bolonio, David Ramos, Hubert Kogler, Gabriele Amann, Roberta Kosova, Mariantonia Maglio, Elke Janssens, Ruth Achten, Pavel Frühauf, Helena Skálová, Thomas Kirchner, Laura Petrarca, Fabio Massimo Magliocca, F. Rocuts Martinez, Vanesa Morente, Sonja Thanner-Lechner, Manfred Ratschek, Marco Gasparetto, Liz Hook, Danielle Canioni, Catherine Wanty, Anne Mourin, Kaija Laurila, Martine Vornane, Vered Nachmias Friedler, Sara Morgenstern, Jorge Amil Dias, Fátima Carneiro, Stéphanie Van Biervliet, Saskia Vande Velde, Hany Banoub, Steve Sampson, Annette Müller, Adina Ene, Mandana Rafeey, Amir Taher Eftekhar Sadat - Gastroenterology 2017 cited by 305

  21. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 cited by 194

  22. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 120

  23. SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis

    Authors: , , , , , , , , , , - Cancer Research 2022 cited by 36

  24. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2021 cited by 30